Image 1 of 1
The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.Cagrilintide is a synthetic peptide analogue that functions as an amylin-receptor agonist. It is a modified form of the human amylin peptide, engineered to enhance molecular stability and receptor selectivity. Amylin itself is a 37–amino acid peptide co-secreted with insulin by pancreatic β-cells, and its analogues are used to investigate pathways related to energy balance, satiety signaling, and glycemic-regulation mechanisms in preclinical research models.
Cagrilintide contains targeted amino-acid substitutions that increase resistance to enzymatic breakdown, yielding improved structural persistence compared to the native peptide. Research efforts focus on its interaction with the amylin-receptor complex—comprising the calcitonin receptor and associated receptor activity-modifying proteins (RAMPs). Ongoing studies examine its pharmacological profile, receptor-binding characteristics, and its utility in metabolic-pathway research.